Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (351-360 of 574) with videos related to

Pageof 58
Sort By:
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerRuoshi Shi, Sebastiao N Martins Filho, Ming Li, et al.
Clinical and Translational Radiation Oncology|February 3, 2025
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapyAbdul H Lone, Rohan Salunkhe, Vijithan Sugumar, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World StudyParneet K Cheema, Iqra Syed, Femida Gwadry-Sridhar, et al.
Cancer Medicine|March 5, 2020
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinomaDi M Jiang, Chihiro Suzuki, Osvaldo Espin-Garcia, et al.
International Journal of Cancer|January 31, 2019
Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck regionJianjun Ren, Wen Yang, Jie Su, et al.
Oral Oncology|June 27, 2021
Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort studyShivakumar Gudi, Brian O'Sullivan, Ali Hosni, et al.
Carcinogenesis|May 28, 2015
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcomeLawson Eng, Abul Kalam Azad, Xin Qiu, et al.
NPJ Precision Oncology|May 18, 2021
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survivalSipeng Shen, Yongyue Wei, Yi Li, et al.
Journal of the National Cancer Institute|December 22, 2020
Potential Molecular Targets in the Setting of Chemoradiation for Esophageal MalignanciesSalma K Jabbour, Terence M Williams, Mutlay Sayan, et al.
Cancer Epidemiology|January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patientsSinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.
Pageof 58

Showing results (351-360 of 574) with videos related to

Sort By:
Pageof 58
Lung Cancer (Amsterdam, Netherlands)|June 11, 2020
BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancerRuoshi Shi, Sebastiao N Martins Filho, Ming Li, et al.
Clinical and Translational Radiation Oncology|February 3, 2025
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapyAbdul H Lone, Rohan Salunkhe, Vijithan Sugumar, et al.
Current Oncology (Toronto, Ont.)|November 26, 2024
Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World StudyParneet K Cheema, Iqra Syed, Femida Gwadry-Sridhar, et al.
Cancer Medicine|March 5, 2020
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinomaDi M Jiang, Chihiro Suzuki, Osvaldo Espin-Garcia, et al.
International Journal of Cancer|January 31, 2019
Human papillomavirus and p16 immunostaining, prevalence and prognosis of squamous carcinoma of unknown primary in the head and neck regionJianjun Ren, Wen Yang, Jie Su, et al.
Oral Oncology|June 27, 2021
Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort studyShivakumar Gudi, Brian O'Sullivan, Ali Hosni, et al.
Carcinogenesis|May 28, 2015
Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcomeLawson Eng, Abul Kalam Azad, Xin Qiu, et al.
NPJ Precision Oncology|May 18, 2021
A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survivalSipeng Shen, Yongyue Wei, Yi Li, et al.
Journal of the National Cancer Institute|December 22, 2020
Potential Molecular Targets in the Setting of Chemoradiation for Esophageal MalignanciesSalma K Jabbour, Terence M Williams, Mutlay Sayan, et al.
Cancer Epidemiology|January 28, 2016
ABCC2 polymorphisms and survival in the Princess Margaret cohort study and the NCIC clinical trials group BR.24 trial of platinum-treated advanced stage non-small cell lung cancer patientsSinead Cuffe, Abul Kalam Azad, Xiaoping Qiu, et al.
Pageof 58